L-JNK Peptide Inhibitor I

Catalog number
7011-50
Name
L-JNK Peptide Inhibitor I
Size
50 µl
Price
285.00 EUR
Supplier

Details

Alternate Name/Synonyms
NA
Appearance
Liquid
Formulation
1 mM (PBS)
CAS Number
N/A
Peptide sequence
GRKKRRQRRR-PP-RPKRPTTLNLFPQVPRSQD-amide
Molecular Formula
C₁₆₄H₂₈₆N₆₆O₄₀
Molecular Weight
3822.5
Purity
≥97% by HPLC
Solubility/Reconstitution Instructions
N/A
Handling
Protect from air and light
Tagline
A cell-permeable JNK inhibitor
Storage Temp.
-20°C
Shipping Conditions
Gel Pack
Shelf Life
12 months
MDL Number
MFCD12912420
PubChem CID
N/A
Category
Biochemicals
Description
Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.